paxilline has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandelman, JD; Smith, RL; Szejnfeld, J; Waitzberg, AF | 1 |
| Bhalla, RC; Fang, S; Sharma, RV | 1 |
2 other study(ies) available for paxilline and Hyperplasia
| Article | Year |
|---|---|
Expression of claudin, paxillin and FRA-1 in non-nodular breast lesions in association with microcalcifications.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Calcinosis; Claudins; Epidemiologic Methods; Female; Humans; Hyperplasia; Paxillin; Precancerous Conditions; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2 | 2013 |
Enhanced recovery of injury-caused downregulation of paxillin protein by eNOS gene expression in rat carotid artery. Mechanism of NO inhibition of intimal hyperplasia?
Topics: Adenoviridae; Animals; Blotting, Western; Carotid Arteries; Carotid Artery Injuries; Catheterization; Citrulline; Cytoskeletal Proteins; Endothelium, Vascular; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Genetic Vectors; Hyperplasia; Male; Nitric Oxide; Nitric Oxide Synthase; Paxillin; Phosphoproteins; Rats; Rats, Sprague-Dawley; Transfection | 1999 |